Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
Recruiting · NCT03983226 · Registry updated 2022-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, primary peritoneal carcinoma | Recruiting | Phase 2 | 2022-03-18 | NCT03983226 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
| Shanghai Gynecologic Oncology Group | 11 |
| Shanghai Jiao Tong University School of Medicine | 117 |
| Sun Yat-sen University | 606 |
| Zhejiang Cancer Hospital | 142 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University | Shanghai | China | 5 |
| Fudan University Shanghai Zhongshan Hospital | Shanghai | China | 1 |
| Shanghai Jiao Tong University | Shanghai | China | 1 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |
| Zhejiang Cancer Hospital | Hangzhou | China | 40 |